NKF KDOQI GUIDELINES

KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease

Figure 1.	Pathogenesis of Abnormalities in Mineral Metabolism and Bone Disease in CKD
Figure 2.	Changes in Total Serum Calcium and Inorganic Phosphorus Observed in 11 Uremic Patients Before and After Subtotal Parathyroidectomy
Figure 3.	Example of Summary ROC Analysis
Figure 4.	Relationship Between PTH and Creatinine Clearance Rate
Figure 5.	Summary ROC Analysis of Erosions on X-Ray as Diagnostic for Osteitis Fibrosa
Figure 6.	Plot of GFR vs. BMD T-Score
Figure 7.	Summary ROC Analysis of Intact PTH for Diagnosis of High-Turnover Bone Disease
Figure 8.	Summary ROC Analysis of Intact PTH for Diagnosis of Low-Turnover Bone Disease
Figure 9.	Relationship Between Serum Phosphorus and Creatinine Clearance Rate (CCR)
Figure 10.	Meta-Analysis of Size of Effect on Serum Phosphorus Levels of Calcium Acetate vs. Calcium Carbonate
Figure 11.	Meta-Analysis of Size of Hypercalcemic Effect of Calcium Carbonate vs. Other Phosphate Binders
Figure 12.	Meta-Analysis of Oral Versus Intravenous Calcitriol on PTH Suppression
Figure 13.	Summary Odds Ratio of Being Diagnosed with A ß₂M Over Time on Dialysis
Figure 14.	Individual Study and Summary Effect Sizes for the Effect of DFO Therapy on Bone Formation Rate
Figure 15.	Individual Study and Summary Effect Sizes for the Effect of DFO Therapy on Bone Surface Aluminum Stain
Figure 16.	Effect Sizes and 95% Confidence Interval of RCTs and Retrospective Studies Reporting Incidence of Necrosis